221 related articles for article (PubMed ID: 30473398)
1. A pilot evaluation of incorporating "opt-out" naloxone dispensing within a chain community pharmacy.
Skoy E
Res Social Adm Pharm; 2019 Aug; 15(8):1043-1046. PubMed ID: 30473398
[No Abstract] [Full Text] [Related]
2. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.
Bailey AM; Wermeling DP
Ann Pharmacother; 2014 May; 48(5):601-6. PubMed ID: 24523396
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Opioid Overdose.
Babu KM; Brent J; Juurlink DN
N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
[No Abstract] [Full Text] [Related]
4. Time for Pharmacy Co-dispensing of Naloxone with Prescribed Opioids?
Wunderlich JR; Engelberg RS; Tofighi B; Schwartz MD
J Gen Intern Med; 2022 Aug; 37(11):2621-2623. PubMed ID: 35581455
[No Abstract] [Full Text] [Related]
5. Concurrent Naloxone Dispensing Among Individuals with High-Risk Opioid Prescriptions, USA, 2015-2019.
Guy GP; Strahan AE; Haegerich T; Losby JL; Ragan K; Evans ME; Jones CM
J Gen Intern Med; 2021 Oct; 36(10):3254-3256. PubMed ID: 33751410
[No Abstract] [Full Text] [Related]
6. Dispensing a Naloxone Kit at Hospital Discharge: A Retrospective QI Project.
Train MK; Patel N; Thapa K; Pasho M; Acquisto NM
Am J Nurs; 2020 Dec; 120(12):48-52. PubMed ID: 33214374
[TBL] [Abstract][Full Text] [Related]
7. The Rhode Island community responds to opioid overdose deaths.
Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
[TBL] [Abstract][Full Text] [Related]
8. Public Health and Pharmacy Partnerships in Opioid Harm Reduction: Responding to Community Needs.
Medina S; Tomaszewski R; Chhen S; Hanson A; Mueller A; Palombi LC
Prog Community Health Partnersh; 2021; 15(1):37-46. PubMed ID: 33775959
[TBL] [Abstract][Full Text] [Related]
9. Some Naloxone Products Could Be Sold Without a Prescription.
Rubin R
JAMA; 2022 Dec; 328(23):2296. PubMed ID: 36538322
[No Abstract] [Full Text] [Related]
10. The changing landscape of naloxone availability in the United States, 2011 - 2017.
Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
[TBL] [Abstract][Full Text] [Related]
11. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes.
Dettmer K; Saunders B; Strang J
BMJ; 2001 Apr; 322(7291):895-6. PubMed ID: 11302902
[No Abstract] [Full Text] [Related]
12. Naloxone Over the Counter: Increasing Opportunities and Challenges for Health Providers.
Ardeljan AD; Fiedler B; Fiedler L; Luck GR; Maki DG; Clayton L; Hennekens CH; Ferris A
Am J Med; 2023 Jun; 136(6):504-506. PubMed ID: 36750143
[No Abstract] [Full Text] [Related]
13. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
[TBL] [Abstract][Full Text] [Related]
14. Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial.
Binswanger IA; Rinehart D; Mueller SR; Narwaney KJ; Stowell M; Wagner N; Xu S; Hanratty R; Blum J; McVaney K; Glanz JM
J Gen Intern Med; 2022 Aug; 37(11):2624-2633. PubMed ID: 35132556
[TBL] [Abstract][Full Text] [Related]
15. Distribution of naloxone for overdose prevention to chronic pain patients.
Coe MA; Walsh SL
Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
[TBL] [Abstract][Full Text] [Related]
16. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.
Green TC; Dauria EF; Bratberg J; Davis CS; Walley AY
Harm Reduct J; 2015 Aug; 12():25. PubMed ID: 26245865
[TBL] [Abstract][Full Text] [Related]
17. A True Antidote.
Berlin J
Tex Med; 2015 Oct; 111(10):41-7. PubMed ID: 26457843
[TBL] [Abstract][Full Text] [Related]
18. Implementation and evaluation of an inpatient naloxone program in a community teaching hospital.
Prach A; Clancy A; LeBlanc M; Thomasian BB; Kelley M; Hogan E; Pawasauskas J
Res Social Adm Pharm; 2019 Aug; 15(8):1037-1042. PubMed ID: 30337179
[No Abstract] [Full Text] [Related]
19. Protecting Against Opioid Overdose: Naloxone Co-Prescribing.
Nathan N
Anesth Analg; 2022 Jul; 135(1):20. PubMed ID: 35709440
[No Abstract] [Full Text] [Related]
20. Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina.
Davis CS; Walley AY; Bridger CM
J Law Med Ethics; 2015; 43 Suppl 1():19-22. PubMed ID: 25846157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
